null

SMILES CN(C)C[C@@H](NC(=O)N1Cc2c(NC(=O)c3ccc(NC(=O)C=C)cc3)[nH]nc2C1(C)C)c1ccccc1

InChI Key InChIKey=KPABJHHKKJIDGX-JOCHJYFZSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 9 hits for monomerid = 50526795   

TargetCyclin-dependent kinase 7(Homo sapiens (Human))
Tianjin University of Science and Technology

Curated by ChEMBL
LigandPNGBDBM50526795(CHEMBL4450322)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Inhibition of CDK7 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q24X5C86PubMed
TargetCDK-activating kinase assembly factor MAT1/Cyclin-H/Cyclin-dependent kinase 7(Homo sapiens (Human))
Eli Lilly and Company

Curated by ChEMBL
LigandPNGBDBM50526795(CHEMBL4450322)copy SMILEScopy InChI
Affinity DataIC50: 53nMAssay Description:Competitive irreversible inhibition of CDK7/cyclinH/MAT1 (unknown origin) in presence of 1 mM ATPMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q23F4T3TPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Lebanese American University

Curated by ChEMBL
LigandPNGBDBM50526795(CHEMBL4450322)copy SMILEScopy InChI
Affinity DataIC50: 1.30E+3nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2C82DT8PubMed
TargetCyclin-dependent kinase 9(Homo sapiens (Human))
Lebanese American University

Curated by ChEMBL
LigandPNGBDBM50526795(CHEMBL4450322)copy SMILEScopy InChI
Affinity DataIC50: 3.02E+3nMAssay Description:Inhibition of CDK9 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2C82DT8PubMed
TargetCyclin-dependent kinase 7(Homo sapiens (Human))
Tianjin University of Science and Technology

Curated by ChEMBL
LigandPNGBDBM50526795(CHEMBL4450322)copy SMILEScopy InChI
Affinity DataIC50: 54nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DF6W53PubMed
TargetCyclin-dependent kinase 7(Homo sapiens (Human))
Tianjin University of Science and Technology

Curated by ChEMBL
LigandPNGBDBM50526795(CHEMBL4450322)copy SMILEScopy InChI
Affinity DataIC50: 9.70nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2BV7MPDPubMed
TargetCyclin-dependent kinase 9(Homo sapiens (Human))
Lebanese American University

Curated by ChEMBL
LigandPNGBDBM50526795(CHEMBL4450322)copy SMILEScopy InChI
Affinity DataIC50: 3.02E+3nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2BV7MPDPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Lebanese American University

Curated by ChEMBL
LigandPNGBDBM50526795(CHEMBL4450322)copy SMILEScopy InChI
Affinity DataIC50: 1.30E+3nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2BV7MPDPubMed
TargetCDK-activating kinase assembly factor MAT1/Cyclin-H/Cyclin-dependent kinase 7(Homo sapiens (Human))
Eli Lilly and Company

Curated by ChEMBL
LigandPNGBDBM50526795(CHEMBL4450322)copy SMILEScopy InChI
Affinity DataIC50: 9.70nMAssay Description:Inhibition of CDK7/cyclin H/MNAT1 (unknown origin) pre incubated up to 60 mins followed by substrate and ATP additionMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2C82DT8PubMed